{"url_path":"/sec/sem/8-k/2026-07-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1320414/0001104659-26-079643-index.html","accession_number":"0001104659-26-079643","cik":"0001320414","ticker":"SEM","issuer_name":"SELECT MEDICAL HOLDINGS CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1320414/0001104659-26-079643-index.html","primary_entity_key":"0001320414","primary_entity_name":"SELECT MEDICAL HOLDINGS CORP"},"word_count":338,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits.**\n\n \n\nExhibit No.\nDescription of Exhibit\n\n[2.1*](https://www.sec.gov/Archives/edgar/data/1320414/000110465926022577/tm267827d1_ex2-1.htm)\n[Agreement and Plan of Merger, dated as of March 2, 2026, by and among Select Medical Holdings Corporation, Parent and Merger Sub (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 3, 2026).](https://www.sec.gov/Archives/edgar/data/1320414/000110465926022577/tm267827d1_ex2-1.htm)\n\n \n \n\n[3.1](tm2619266d7_ex3-1.htm)\n[Amended and Restated Certificate of Incorporation of the Company.](tm2619266d7_ex3-1.htm)\n\n \n \n\n[3.2](tm2619266d7_ex3-2.htm)\n[Amended and Restated Bylaws of the Company.](tm2619266d7_ex3-2.htm)\n\n \n \n\n[10.1](tm2619266d7_ex10-1.htm)\n[Amendment No. 12, dated June 30, 2026, to the Credit Agreement, dated as of March 6, 2017, by and among Select Medical Holdings Corporation, Select Medical Corporation, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and the other lenders and issuing banks party thereto, as amended by Amendment No. 1, dated as of March 22, 2018, Amendment No. 2, dated as of October 26, 2018, Amendment No. 3, dated as of August 1, 2019, Amendment No. 4, dated as of December 10, 2019, Amendment No. 5, dated as of June 2, 2021, Amendment No. 6, dated as of February 21, 2023, Amendment No. 7, dated as of May 31, 2023, Amendment No. 8, dated as of July 31, 2023, Amendment No. 9, dated as of August 31, 2023, Amendment No. 10, dated as of July 26, 2024 and Amendment No. 11, dated as of December 3, 2024.](tm2619266d7_ex10-1.htm)\n\n \n \n\n[99.1](tm2619266d7_ex99-1.htm)\n[Press Release of Select Medical Holdings Corporation issued on June 30, 2026.](tm2619266d7_ex99-1.htm)\n\n \n \n\n104\nCover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).\n\n \n\n*Exhibits and schedules omitted\npursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted exhibit or schedule will be furnished supplementally to the SEC upon\nrequest.\n\n \n\n3\n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \nSELECT MEDICAL HOLDINGS CORPORATION\n\n \n\nDate: July 1, 2026\nBy:\n/s/ John F. Duggan\n\n \n \nJohn F. Duggan\n\n \n \nExecutive Vice President, General Counsel and Secretary\n\n \n\n4"}